Driving ALS Discovery With Integrative Genomics | Jan Veldink

31 October 2016

Jan Veldink, PhD shares how integrative genomics has helped drive his ALS research, leading to the discovery that NEK1 is an ALS gene. He highlights why using a combination of methods including GWAS, whole genome sequencing, and whole exome sequencing was critical to his teams’ NEK1 breakthrough. He also describes how integrating methylation data with genomic data may help to develop a complete picture of the disease. Presenter: Jan Veldink, PhD Professor of Neurology and Neurogenetics University Medical Center Utrecht, Netherlands A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on